A REGIONAL ANALYSIS OF RELAPSING REMITTING MS (RRMS) PATIENTS TREATED WITH NATALIZUMAB SUGGESTS A NEED TO DIAGNOSE AND TREAT EARLY IN LATIN AMERICANS

Author(s)

Serafini P1, Callegaro D2, Apostolos S2, Sato D3, Jones E4, Pike J5
1Biogen, Sao Paulo, Brazil, 2Hospital Das Clinicas, Sao Paulo, Brazil, 3Hospital São Lucas da PUCRS, Porto Alegre, Brazil, 4Adelphi Real World, Manchester, UK, 5Adelphi Real World, Bollington, UK

OBJECTIVES:  

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PND67

Topic

Epidemiology & Public Health, Health Policy & Regulatory, Health Service Delivery & Process of Care

Topic Subcategory

Disease Classification & Coding, Health Disparities & Equity, Hospital and Clinical Practices, Prescribing Behavior, Pricing Policy & Schemes, Public Health, Treatment Patterns and Guidelines

Disease

Neurological Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×